An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration datesort descending
Strategies to Reduce Clostridioides Difficile Infection in Hematologic Malignancies 0.75 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Management of Cardiac Complications in Hematologic Malignancies 0.75 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Advances and Innovations in Multiple Myeloma 0.75 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Lymphoma 101: The Plot Thickens 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Navigating the Jargon of Molecular Testing 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Controversies in the Management of Early-Stage Hodgkin Lymphoma 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Updates in the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Sequencing Therapy and the Role of MRD Testing 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Challenges and Opportunities in Marginal Zone Lymphoma: Implications of Biology on Treatment 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma: Is it Time to Consider CAR T for All? 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Peripheral T-Cell Lymphomas-Not Otherwise Specified: A Shrinking Entity? 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Emerging Therapeutic Options in Acute Lymphoblastic Leukemia 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Advances in Acute Myeloid Leukemia (AML) Management: Focus on Secondary AML and Older Patients with AML 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Myeloproliferative Neoplasms: Emerging Treatment Options for Myelofibrosis 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Evolving Concepts in the Diagnosis and Staging of Multiple Myeloma 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am
Bonanza of New Treatment Regimens for Multiple Myeloma: What is Right for My Patient? 0.50 10/30/2020 - 12:00am to 10/30/2021 - 12:00am

Pages